Involvement of angiotensin II and reactive oxygen species in pancreatic fibrosis

Pancreatology

Volumn 11, Issue SUPPL. 2, 2011, Pages 7-13

  Sakurai, Toshiharu ^a   Kudo, Masatoshi ^a   Fukuta, Nobuhiro ^a   Nakatani, Tatsuya ^a   Kimura, Masatomo ^a   Park, Ah Mee ^a   Munakata, Hiroshi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin receptor blocker; AT1R; Pancreatic fibrosis; Reactive oxygen species; Wistar Bonn Kobori rat; Smooth muscle actin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 14; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYSTIC FIBROSIS; MALE; NONHUMAN; PANCREAS CANCER; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

EID: 79953826393     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000323478     Document Type: Article

References (32)

1. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, et al: Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433-1437. (Pubitemid 23143844)
2. Ammann RW, Muellhaupt B: Progression of alcoholic acute to chronic pancreatitis. Gut 1994;35:552-556. (Pubitemid 24131256)
3. Oparil S, Haber E: The renin-angiotensin system. N Engl J Med 1974;291:389-401.
4. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, et al: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45: 205-251. (Pubitemid 23191415)
5. Dijkhorst-Oei LT, Stroes ES, Koomans HA, Rabelink TJ: Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J Cardiovasc Pharmacol 1999;33:420-424. (Pubitemid 29101986)
6. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG: Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002;40:511-515.
7. Reinehr R, Zoller S, Klonowski-Stumpe H, Kordes C, Häussinger D: Effects of angiotensin II on rat pancreatic stellate cells. Pancreas 2004;28:129-137. (Pubitemid 38269772)
8. Yamada T, Kuno A, Masuda K, Ogawa K, Sogawa M, Nakamura S, et al: Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 2003;307: 17-23. (Pubitemid 37151887)
9. Ulmasov B, Xu Z, Talkad V, Oshima K, Neuschwander-Tetri BA: Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse. Am J Physiol Gastrointest Liver Physiol 2010;299:G70-G80.
10. Tsang SW, Ip SP, Wong TP, Che CT, Leung PS: Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 2003;111:47-53. (Pubitemid 36254748)
11. Tsang SW, Ip SP, Leung PS: Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 2004;36:330-339. (Pubitemid 37487767)
12. Apte MV, Phillips PA, Fahmy RG, Darby SJ, Rodgers SC, McCaughan GW, et al: Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology 2000;118:780-794. (Pubitemid 30171628)
13. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, et al: Angiotensin-II type I receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001;94:745-750. (Pubitemid 32927999)
14. Nishida K, Yamaguchi O, Hirotani S, Hikoso S, Higuchi Y, Watanabe T, et al: p38α mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol Cell Biol 2004;24: 10611-10620. (Pubitemid 39603120)
15. Sakurai T, He G, Matsuzawa A, Yu GY, Maeda S, Hardiman G, et al: Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008;14:156-165.
16. Passino MA, Adams RA, Sikorski SL, Akassoglou K: Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 2007;315:1853-1856. (Pubitemid 46580146)
17. Masamune A, Suzuki N, Kikuta K, Satoh M, Satoh K, Shimosegawa T: Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 2006;97:1080-1093.
18. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, Brenner DA: The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 2001;34:89-100. (Pubitemid 32591487)
19. Shimizu K: Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol 2008; 43:823-832.
20. Klöppel G, Maillet B: The morphological basis for the evolution of acute pancreatitis into chronic pancreatitis. Virchows Arch A Pathol Anat Histopathol 1992;420:1-4.
21. Neuschwander-Tetri BA, Bridle KR, Wells LD, Marcu M, Ramm GA: Repetitive acute pancreatic injury in the mouse induces procollagen alpha1(I) expression colocalized to pancreatic stellate cells. Lab Invest 2000;80: 143-150.
22. Van Laethem JL, Robberecht P, Résibois A, Devière J: Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 1996;110:576-582. (Pubitemid 26043892)
23. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005;115:209-218. (Pubitemid 40385459)
24. Wada T, Inada Y, Ojima M, Sanada T, Shibouta Y, Nishikawa K: Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats. Hypertens Res 1996;19:75-81.
25. Ulmasov B, Xu Z, Tetri LH, Inagami T, Neuschwander-Tetri BA: Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2009; 296:G284-G294.
26. Ames BN: Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983;221:1256-1264.
27. Woo RA, Poon RY: Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev 2004;18:1317-1330. (Pubitemid 38720599)
28. Allen RG, Tresini M: Oxidative stress and gene regulation. Free Radic Biol Med 2000; 28:463-499. (Pubitemid 30110662)
29. Toyokuni S: Novel aspects of oxidative stress-associated carcinogenesis. Antioxid Redox Signal 2006;8:1373-1377.
30. Dhillon AS, Hagan S, Rath O, Kolch W: MAP kinase signalling pathways in cancer. Oncogene 2007;26:3279-3290. (Pubitemid 46763021)
31. Cuenda A, Rousseau S: p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007; 1773:1358-1375. (Pubitemid 47125981)
32. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA: Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 2000;191:859-870.